Sanofi (Global Rights to Enjaymo) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Sanofi (Global Rights to Enjaymo) General Information
Description
A global rights to Enjaymo located in the United States. The asset consists of global rights to Enjaymo treatment of cold agglutinin disease (CAD), a rare B-cell lymphoproliferative disorder.
Contact Information
Corporate Office
- United States
Corporate Office
- United States
Sanofi (Global Rights to Enjaymo) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sanofi (Global Rights to Enjaymo) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sanofi (Global Rights to Enjaymo) FAQs
-
Where is Sanofi (Global Rights to Enjaymo) headquartered?
Sanofi (Global Rights to Enjaymo) is headquartered in .
-
What industry is Sanofi (Global Rights to Enjaymo) in?
Sanofi (Global Rights to Enjaymo)’s primary industry is Buildings and Property.
-
Is Sanofi (Global Rights to Enjaymo) a private or public company?
Sanofi (Global Rights to Enjaymo) is a Private company.
-
What is the current valuation of Sanofi (Global Rights to Enjaymo)?
The current valuation of Sanofi (Global Rights to Enjaymo) is .
-
What is Sanofi (Global Rights to Enjaymo)’s current revenue?
The current revenue for Sanofi (Global Rights to Enjaymo) is .
-
Who are Sanofi (Global Rights to Enjaymo)’s investors?
Sanofi has invested in Sanofi (Global Rights to Enjaymo).
-
When was Sanofi (Global Rights to Enjaymo) acquired?
Sanofi (Global Rights to Enjaymo) was acquired on 29-Nov-2024.
-
Who acquired Sanofi (Global Rights to Enjaymo)?
Sanofi (Global Rights to Enjaymo) was acquired by Recordati.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process